Neurogene (NGNE) Enterprise Value Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Neurogene 632.14 Mn 632.14 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.89%
Dec 31, 2025 13.89%
Sep 30, 2025 -90.95%
Jun 30, 2025 -78.37%
Mar 31, 2025 -72.59%
Dec 31, 2024 -58.45%
Sep 30, 2024 -77.05%
Jun 30, 2024 -87.55%
Mar 31, 2024 -103.19%
Dec 31, 2023 -140.37%
Sep 30, 2023 26.55%
Jun 30, 2023 29.53%
Mar 31, 2023 34.84%
Dec 31, 2022 42.43%
Sep 30, 2022 31.01%
Jun 30, 2022 29.09%
Mar 31, 2022 28.22%
Dec 31, 2021 26.01%
Sep 30, 2021 22.98%
Jun 30, 2021 -26.73%
Mar 31, 2021 -50.92%
Dec 31, 2020 -34.57%
Sep 30, 2020 -203.37%
Jun 30, 2020 -160.92%
Mar 31, 2020 -393.14%
Dec 31, 2019 -86.01%
Sep 30, 2019 23.55%
Jun 30, 2019 4.94%
Mar 31, 2019 74.13%
Dec 31, 2018 -12.08%
Sep 30, 2018 9.80%
Jun 30, 2018 60.20%
Mar 31, 2018 23.79%
Dec 31, 2017 33.40%
Sep 30, 2017 34.11%
Jun 30, 2017 -97.23%
Mar 31, 2017 -76.94%
Dec 31, 2016 -38.37%
Sep 30, 2016 -24.29%
Jun 30, 2016 -129.32%
Mar 31, 2016 -99.65%
Dec 31, 2015 -90.51%
Sep 30, 2015 -193.50%
Jun 30, 2015 19.12%
Mar 31, 2015 38.13%
Dec 31, 2014 -182.77%
Sep 30, 2014 -152.10%
Jun 30, 2014 -104.01%
Mar 31, 2014 -192.53%